Comments to DEA: Exemption of Sales by Retail Distributors of Pseudoephedrine and Phenylpropanolamine Products

Share page:

Letter | Feb 27, 2004

Docket Number:
DEA-239T

These comments are in response to the "interpretive rule" DEA published to provide a "Clarification of the Exemption of Sales by Retail Distributors of Pseudoephedrine and Phenylpropanolamine Products."

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement: OTC Pain Relievers and COVID-19 Vaccines